login
login
Image header Agence Europe
Europe Daily Bulletin No. 13047
Contents Publication in full By article 22 / 28
EU RESPONSE TO COVID-19 / Health

EMA recommends Spikevax vaccine adapted for BA.4 and BA.5 and opens door to vaccination of young children

The European Medicines Agency (EMA) issued several recommendations on Wednesday 19 October in favour of vaccines against Covid-19.

The EMA is recommending the authorisation of the bivalent Covid-19 vaccine (Spikevax) developed by the pharmaceutical company Moderna, adapted not only to fight the original SARS-CoV-2 strain, but also two of its sub-variants of concern: BA.4 and BA.5. This vaccine is intended for people over 12 years of age who have already completed a first vaccination...

Contents

EUROPEAN COUNCIL
Russian invasion of Ukraine
SECTORAL POLICIES
EUROPEAN PARLIAMENT PLENARY
ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COURT OF JUSTICE OF THE EU
NEWS BRIEFS